Brevel has constructed its first pilot facility in Southern Israel, equipped with proprietary industrial-scale fermenters for microalgae protein, while securing two commercial agreements with “leading food and beverage companies” for the supply of its sustainable ingredient. Brevel cultivates its microalgae in indoor bioreactors through fermenting sugars. Its “FOAK (First-Of-A-Kind)” facility will showcase the new technology at commercial scale for the first time to investors, customers and partners in real-world applications.
